MediWound Company Profile (NASDAQ:MDWD)

Analyst Ratings

Consensus Ratings for MediWound (NASDAQ:MDWD) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.00 (93.08% upside)

Analysts' Ratings History for MediWound (NASDAQ:MDWD)
Show:
DateFirmActionRatingPrice TargetActions
4/23/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016SunTrust Banks Inc.Initiated CoverageBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Jefferies GroupBoost Price TargetBuy$13.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2016Oppenheimer Holdings Inc.Reiterated RatingOutperform$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Credit Suisse Group AGLower Price TargetOutperform$18.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for MediWound (NASDAQ:MDWD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/1/2016        
4/21/2016Q116($0.24)($0.17)$0.28 million$0.25 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2016Q415($0.23)($0.36)$0.40 million$0.27 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315($0.31)($0.17)$0.47 million$334.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2015Q215($0.26)($0.19)$0.22 million$0.17 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2015($0.26)($0.30)$0.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q4($0.26)($0.33)$0.09 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q3($0.23)($0.24)$0.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q2($0.15)($0.28)$0.19 million$0.89 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2014($0.11)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MediWound (NASDAQ:MDWD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.28)($0.22)($0.25)
Q2 20163($0.25)($0.23)($0.24)
Q3 20163($0.26)($0.17)($0.21)
Q4 20163($0.30)($0.23)($0.26)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for MediWound (NASDAQ:MDWD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MediWound (NASDAQ:MDWD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for MediWound (NASDAQ:MDWD)
DateHeadline
07/21/16 07:00 AMMediWound to Host Second Quarter 2016 Financial Results Conference Call on July 28, 2016 at 8:30 a.m. Eastern Time - [GlobeNewswire] - YAVNE, Israel, July 21, 2016-- MediWound Ltd., a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announces that ...
07/14/16 06:01 AMBear of the Day: Valeant Pharma (VRX) -
06/28/16 12:16 PMMediWound Ltd. :MDWD-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 -
06/07/16 06:00 AMMediWound’s NexoBrid® Receives Reimbursement in Italy - [GlobeNewswire] - YAVNE, Israel, June 07, 2016-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that the ...
05/31/16 06:30 AMData Published in Bone & Joint Research Supports MediWound’s Bromelain-Based Enzyme for the Release of Dupuytren’s Contracture - [GlobeNewswire] - YAVNE, Israel, May 31, 2016-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that a comprehensive ...
05/30/16 05:09 PMMediWound Ltd. (NASDAQ:MDWD) Daily Sentiment Score Of 0.31 - RealistInvestor.com - MediWound Ltd. (NASDAQ:MDWD) Daily Sentiment Score Of 0.31RealistInvestor.comMediWound Ltd. (NASDAQ:MDWD) has a daily sentiment score of 0.31. This score is given by Alpha One, which uses its self-designed algorithm to identify market sentiment on the stock after studying the published content on the web. The content for ...and more »
05/29/16 04:59 PMMediwound Limited Ord (NASDAQ:MDWD) Short Interest Increased By 2.83% - HNN - Mediwound Limited Ord (NASDAQ:MDWD) Short Interest Increased By 2.83%HNNThe stock of Mediwound Limited Ord (NASDAQ:MDWD) registered an increase of 2.83% in short interest. MDWD's total short interest was 112,700 shares in May as published by FINRA. Its up 2.83% from 109,600 shares, reported previously. With 6,000 ...and more »
05/22/16 04:33 PMMediWound Ltd. (MDWD) Broker Price Targets For The Coming Week - Share Trading News - MediWound Ltd. (MDWD) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of MediWound Ltd. (MDWD). The latest reports which are currently in issue on Sunday 22nd of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...and more »
05/19/16 06:00 AMMediWound’s NexoBrid® Highlighted in “Best Oral Presentation” at the British Burn Association 49th Annual Conference and Scientific Meeting - [GlobeNewswire] - YAVNE, Israel, May 19, 2016-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that an abstract ...
05/06/16 04:00 AMBroker Outlook For MediWound Ltd. (MDWD) - Share Trading News - Broker Outlook For MediWound Ltd. (MDWD)Share Trading NewsThe most recently updated broker views and price targets issued for MediWound Ltd. (MDWD) are below. 03/23/2016 – Broker: SunTrust Rating: buy New Target: 13 newcoverage. 02/03/2016 – Broker: Jefferies Rating: buy New Target: 15 reiteration.
05/02/16 05:46 PMMediWound's NexoBrid® To Be Highlighted In Presentations At The American Burn Association 48th Annual Meeting - YAVNE, Israel, May 02, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that 11 presentations ...
05/02/16 06:00 AMMediWound’s NexoBrid® to be Highlighted in Presentations at the American Burn Association 48th Annual Meeting - [GlobeNewswire] - YAVNE, Israel, May 02, 2016-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that 11 presentations ...
05/02/16 04:15 AMMediwound Limited Ord (NASDAQ:MDWD) Short Interest Decreased By 0.28% - B.O.D.Y Confidential - Mediwound Limited Ord (NASDAQ:MDWD) Short Interest Decreased By 0.28%B.O.D.Y ConfidentialThe stock of Mediwound Limited Ord (NASDAQ:MDWD) registered a decrease of 0.28% in short interest. MDWD's total short interest was 106,200 shares in May as published by FINRA. Its down 0.28% from 106,500 shares, reported previously. With 12,600 ...and more »
04/28/16 05:45 PMLatest Analyst Ratings For MediWound Ltd. (MDWD) - Share Trading News - Latest Analyst Ratings For MediWound Ltd. (MDWD)Share Trading News01/08/2016 – Brean Capital began new coverage on MediWound Ltd. giving the company a “buy” rating. They now have a USD 20 price target on the stock. 08/11/2015 – MediWound Ltd. had its “outperform” rating reiterated by analysts at Credit Suisse.
04/26/16 05:51 PMMediWound Ltd. (MDWD) Latest Broker Views - Risers & Fallers - MediWound Ltd. (MDWD) Latest Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of MediWound Ltd. (MDWD). According to the latest broker reports outstanding on Tuesday 26th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...
04/26/16 06:00 AMMediWound’s NexoBrid to be Available in Japan through Kaken Pharmaceuticals Co., Ltd. - [GlobeNewswire] - YAVNE, Israel, April 26, 2016-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces the signing ...
04/23/16 05:22 PMQ1 Results: Mediwound Ltd (MDWD) - share market updates (press release) - share market updates (press release)Q1 Results: Mediwound Ltd (MDWD)share market updates (press release)Shares of Mediwound Ltd (NASDAQ:MDWD) closed at $8.26 with 9,268.00 shares getting traded. Post opening the session at $8.27, the shares hit an intraday low of $8.14 and an intraday high of $8.52 and the price vacillated in this range throughout the day.
04/22/16 05:44 PMMediWound Ltd. (MDWD) - Broker Update - Risers & Fallers - MediWound Ltd. (MDWD) - Broker UpdateRisers & FallersBelow are the most recently updated broker updates which include ratings and price targets for MediWound Ltd. (MDWD). 03/23/2016 – Broker: SunTrust Rating: buy New Target: 13 newcoverage. 02/03/2016 – Broker: Jefferies Rating: buy New Target: 15 ...
04/22/16 08:55 AMMediWound Ltd. :MDWD-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/21/16 05:44 PMConference Call Info: Mediwound Ltd (NASDAQ:MDWD) - share market updates (press release) - share market updates (press release)Conference Call Info: Mediwound Ltd (NASDAQ:MDWD)share market updates (press release)Shares of Mediwound Ltd (NASDAQ:MDWD) ended Wednesday session in red amid volatile trading. The shares closed down -0.17 points or -2.02% at $8.25 with 25,307.00 shares getting traded. Post opening the session at $8.39, the shares hit an intraday ...MediWound Ltd. (NASDAQ:MDWD) To Release EarningsRisers & FallersMediwound Ltd (MDWD) Posts Earnings Results, Beats Expectations By $0.07 EPSMas Market NewsMediwound Ltd (MDWD) Releases Earnings Results, Beats Expectations By $0.07 EPSMarket DigestSonoran Weekly Review -GlobeNewswire (press release) -Money Morningall 8 news articles »
04/21/16 02:12 PMEdited Transcript of MDWD earnings conference call or presentation 21-Apr-16 12:30pm GMT -
04/21/16 08:17 AMMediWound reports 1Q loss -
04/21/16 06:07 AMQ1 2016 Mediwound Ltd Earnings Release - 07:00 am ET -
04/21/16 06:06 AM7:06 am MediWound beats by $0.07, misses on revs -
04/21/16 06:00 AMMediWound Reports First Quarter 2016 Financial Results - [GlobeNewswire] - YAVNE, Israel, April 21, 2016-- MediWound Ltd., a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, reports financial ...
04/20/16 05:39 PMWhy MediWound (MDWD) Might Surprise This Earnings Season - Investors are always looking for stocks that are poised to beat at earnings season and MediWound Ltd. (MDWD - Snapshot Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
04/19/16 09:45 AMThis Isn't a Time to Be Too Clever -
04/19/16 04:04 AMMediwound Limited Ord (NASDAQ:MDWD) Shorted Shares Decreased By 8.43% - Stock Caller - Mediwound Limited Ord (NASDAQ:MDWD) Shorted Shares Decreased By 8.43%Stock CallerThe stock of Mediwound Limited Ord (NASDAQ:MDWD) registered a decrease of 8.43% in short interest. MDWD's total short interest was 106,500 shares in April as published by FINRA. Its down 8.43% from 116,300 shares, reported previously. With 10,400 ...and more »
04/15/16 05:38 PMBroker Roundup For MediWound Ltd. (MDWD) - Share Trading News - Broker Roundup For MediWound Ltd. (MDWD)Share Trading News04/14/2014 – BMO Capital Markets began new coverage on MediWound Ltd. giving the company a “outperform” rating. They now have a USD 20 price target on the stock. The share price of MediWound Ltd. (MDWD) was up +2.69% during the last trading ...
04/15/16 05:38 PMMediwound Ltd (NASDAQ:MDWD) Given Average Rating of “Buy” by Brokerages - Washington News Wire - Mas Market NewsMediwound Ltd (NASDAQ:MDWD) Given Average Rating of “Buy” by BrokeragesWashington News WireMediwound logo Mediwound Ltd (NASDAQ:MDWD) has earned an average recommendation of “Buy” from the six brokerages that are currently covering the company, AnalystRatings.Net reports. One research analyst has rated the stock with a sell ...Mediwound Ltd (NASDAQ:MDWD) Given Average Rating of "Buy" by BrokeragesMas Market Newsall 2 news articles »
04/14/16 06:00 AMMediWound to Host First Quarter 2016 Financial Results Conference Call on April 21, 2016 at 8:30 a.m. Eastern Time - [GlobeNewswire] - YAVNE, Israel, April 14, 2016-- MediWound Ltd., a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announces that ...
04/12/16 05:43 PMAEterna Zentaris (NASDAQ:AEZS) & Mediwound (NASDAQ:MDWD) Stocks in Queue - Wall Street 24 - AEterna Zentaris (NASDAQ:AEZS) & Mediwound (NASDAQ:MDWD) Stocks in QueueWall Street 24MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound administration, declared that top-line data from a multicenter Phase 2 clinical study of the Company's ...
04/12/16 05:43 PMMediWound Ltd. (MDWD) Latest Broker Coverage - Risers & Fallers - MediWound Ltd. (MDWD) Latest Broker CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of MediWound Ltd. (MDWD). According to the latest broker reports outstanding on Tuesday 12th of April, 3 analysts have a rating of “strong buy”, 2 analysts “buy”, 0 ...MediWound Ltd. (NASDAQ:MDWD): Quarterly EPS Estimate Of $-0.25Equities Focusall 2 news articles »
04/11/16 09:07 AMAnalyst Review: MediWound Ltd. (MDWD) - Risers & Fallers - Analyst Review: MediWound Ltd. (MDWD)Risers & FallersA number of investment brokers have recently updated their price targets on shares of MediWound Ltd. (MDWD). According to the latest broker reports outstanding on Monday 11th of April, 3 analysts have a rating of “strong buy”, 2 analysts “buy”, 0 ...and more »
04/09/16 05:02 PMMediWound (MDWD) Announces Results From Phase 2 Study With EscharEx to Treat Chronic Wounds Will be Presented at SAWC - Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management ...
04/08/16 05:50 PMMediwound Limited Ord (NASDAQ:MDWD) Short Interest Increased By 3.38% - Clinton Financial - Mediwound Limited Ord (NASDAQ:MDWD) Short Interest Increased By 3.38%Clinton FinancialThe stock of Mediwound Limited Ord (NASDAQ:MDWD) registered an increase of 3.38% in short interest. MDWD's total short interest was 116,300 shares in April as published by FINRA. Its up 3.38% from 112,500 shares, reported previously. With 23,700 ...and more »
04/08/16 05:50 PMMediwound Reports Top-Line Results from Phase 2 Study with EscharEx to Treat Chronic Wounds Will Be Presented ... - Benzinga - Mediwound Reports Top-Line Results from Phase 2 Study with EscharEx to Treat Chronic Wounds Will Be Presented ...BenzingaMediWound Ltd. MDWD, a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that top-line data from a multicenter Phase 2 clinical study of the Company's ...MediWound Reports Positive Data from Trial of EscharEx to Treat Chronic Wounds; Shares Flat in Pre Market ...Sonoran Weekly Reviewall 2 news articles »
04/08/16 05:50 PMUpgrades And Downgrades For MediWound Ltd. (MDWD) - Risers & Fallers - Upgrades And Downgrades For MediWound Ltd. (MDWD)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of MediWound Ltd. (MDWD). The latest broker reports which are currently outstanding on Friday 8th of April state 3 analysts have a rating of “strong buy”, 2 analysts “buy”, ...
04/08/16 06:00 AMTop-Line Results from Phase 2 Study with MediWound’s EscharEx to Treat Chronic Wounds Will be Presented at the Symposium on Advanced Wound Care Spring 2016 - [GlobeNewswire] - YAVNE, Israel, April 08, 2016-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that top-line ...
04/06/16 06:00 AMMediWound to Present at Needham & Company’s 15th Annual Healthcare Conference - [GlobeNewswire] - YAVNE, Israel, April 06, 2016-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that Company ...
04/04/16 09:17 AMMediWound Ltd. (MDWD) Updated Analyst Coverage - Risers & Fallers - MicroCap MagazineMediWound Ltd. (MDWD) Updated Analyst CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of MediWound Ltd. (MDWD). According to the latest broker reports outstanding on Monday 4th of April, 3 analysts have a rating of “strong buy”, 2 analysts “buy”, 0 ...Mediwound Limited Ord (NASDAQ:MDWD) Shorted Shares Increased 3.38% After Market SellingFranklin IndependentMediwound Ltd (MDWD) Downgraded by Zacks Investment ResearchMicroCap MagazineNext Weeks Broker Price Targets For MediWound Ltd. (MDWD)Share Trading Newsall 4 news articles »
04/04/16 07:33 AMWhy MediWound (MDWD) Stock Might be a Great Pick -
03/07/16 06:00 AMMediWound to Present at the 36th Annual Cowen Health Care Conference - [GlobeNewswire] - YAVNE, Israel, March 07, 2016-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that Company ...
02/29/16 05:00 AMMediWound Expands NexoBrid to India, Bangladesh and Sri Lanka Through Distribution Agreement With Learning Organized LLC - [GlobeNewswire] - YAVNE, Israel, Feb. 29, 2016-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces the signing ...
02/02/16 03:55 PMMediWound’s EscharEx® Meets Primary Endpoint in Second Phase 2 Clinical Trial for the Debridement of Chronic and Hard-to-Heal Wounds - [GlobeNewswire] - Data demonstrate strong results in diabetic foot ulcers and venous leg ulcers. Conference call with MediWound management and key opinion leader begins February 3, 2016 at 8:30 a.m. Eastern time. YAVNE, ...
01/29/16 11:58 AMMediWound Ltd. Earnings Analysis: Q4, 2015 By the Numbers -
01/26/16 07:26 AMEdited Transcript of MDWD earnings conference call or presentation 25-Jan-16 1:30pm GMT -
01/25/16 07:30 AMMediwound Ltd Earnings Call scheduled for 8:30 am ET today -
01/25/16 06:19 AMMediWound reports 4Q loss -
01/25/16 06:07 AMQ4 2015 Mediwound Ltd Earnings Release - 07:00 am ET -

Social

About MediWound

MediWound logoMediWound Ltd. is a biopharmaceutical company focused on developing, manufacturing and commercializing products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's biopharmaceutical product, NexoBrid, received marketing authorization from the European Union agency (EMA) and the Israeli and Argentinean ministries of health for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full thickness thermal burns, also referred to as severe burns. NexoBrid is based on the Company's proteolytic enzyme technology. NexoBrid is a topically-applied product that removes eschar in approximately four hours without harming the surrounding healthy tissues. The Company offers NexoBrid in Europe and Israel. NexoBrid has been investigated in over 550 patients across approximately 15 countries and over four continents in approximately six completed Phase II and Phase III clinical studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MDWD
  • CUSIP:
Key Metrics:
  • Previous Close: $7.77
  • 50 Day Moving Average: $7.898
  • 200 Day Moving Average: $7.734
  • P/E Ratio: N/A
  • P/E Growth: -0.290
  • Market Cap: $169.75M
  • Beta: 0.07
  • Current Year EPS Consensus Estimate: $-0.78 EPS
  • Next Year EPS Consensus Estimate: $-0.72 EPS
Additional Links:
MediWound (NASDAQ:MDWD) Chart for Monday, July, 25, 2016